ArticleCureus2026
Secondary Hypertension and Renal Atrophy Unmasking Takayasu Arteritis With Renal Artery Stenosis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Takayasu arteritis is a rare inflammatory arteriopathy predominantly affecting young women and representing an important, often under-recognized, cause of secondary hypertension. Diagnosis is frequently delayed due to nonspecific early manifestations, while advanced vascular lesions may already be established at presentation. A 25-year-old woman with no prior history was referred for incidentally discovered hypertension. Workup excluded common secondary causes but showed elevated inflammatory markers. Imaging revealed severe left renal atrophy with renal artery occlusion, circumferential suprarenal abdominal aortic wall thickening, and superior mesenteric artery ostial stenosis on computed tomography angiography. Takayasu arteritis was diagnosed. Hypertension was attributed to renovascular disease, but revascularization was not indicated due to advanced renal atrophy. The patient was treated with corticosteroids and optimized antihypertensive therapy. This case underscores the insidious presentation of Takayasu arteritis and the pivotal role of imaging in diagnosing active inflammatory lesions. It highlights renovascular hypertension as a key manifestation and emphasizes the importance of assessing renal viability when considering revascularization. In advanced unilateral renal atrophy, the benefit of intervention is limited, and management should prioritize medical therapy. Takayasu arteritis should be considered in young patients with unexplained hypertension and inflammatory syndrome. Early recognition and imaging are essential to guide management and avoid unnecessary interventions in advanced disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.